Lower-Cost Contingency Management in a Group Setting - 1
Primary Purpose
Substance Abuse
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Contingency management
Sponsored by
About this trial
This is an interventional treatment trial for Substance Abuse focused on measuring contingency management, substance abuse
Eligibility Criteria
Inclusion criteria: HIV-positive and a member of The Living Center or the Manchester Area Network on AIDS DSM-IV diagnosis of current opioid or cocaine abuse or dependence willingness to accept random assignment to one of the two treatment groups Exclusion criteria: inability to comprehend the study (Mini-mental status score <21; Folstein & Folstein, 1975; or inability to pass an informed consent quiz) severely disruptive behavior in recovery for pathological gambling (due to potential similarity between the CM procedure and gambling) non-English speaking
Sites / Locations
- University of Connecticut Health Center
Outcomes
Primary Outcome Measures
Drug use
Secondary Outcome Measures
Full Information
NCT ID
NCT00249600
First Posted
November 3, 2005
Last Updated
November 17, 2011
Sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT00249600
Brief Title
Lower-Cost Contingency Management in a Group Setting - 1
Official Title
Lower-Cost Contingency Management in a Group Setting
Study Type
Interventional
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
March 2003 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
December 2007 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the efficacy of prize contingency management (CM) in enhancing attendance, reducing drug use, and improving health among clients attending two HIV drop-in centers. Specifically, 172 clients are randomly assigned to one of two 6-month treatment conditions: standard 12-step oriented group treatment, or CM group treatment. In the CM group, clients earn the chance to win prizes for submitting clean urine specimens and for complying with steps toward their treatment goals. Activities related to improving health will be emphasized, such as attending medical appointments, recording daily medication consumption, getting prescriptions filled, and attending medication adherence support groups. Group attendance, drug use, medical problems, services received, and risky drug use and sexual behaviors will be measured pre-treatment and at months 1, 3, 6, 9 and 12.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance Abuse
Keywords
contingency management, substance abuse
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
172 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Contingency management
Primary Outcome Measure Information:
Title
Drug use
Time Frame
baseline and each follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
HIV-positive and a member of The Living Center or the Manchester Area Network on AIDS
DSM-IV diagnosis of current opioid or cocaine abuse or dependence
willingness to accept random assignment to one of the two treatment groups
Exclusion criteria:
inability to comprehend the study (Mini-mental status score <21; Folstein & Folstein, 1975; or inability to pass an informed consent quiz)
severely disruptive behavior
in recovery for pathological gambling (due to potential similarity between the CM procedure and gambling)
non-English speaking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy Petry, Ph.D.
Organizational Affiliation
UConn Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Connecticut Health Center
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06030 2103
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Lower-Cost Contingency Management in a Group Setting - 1
We'll reach out to this number within 24 hrs